Suboxone Lawsuit Claim – Top Class Actions website and social media posts use affiliate links. If you make a purchase using this link, we may receive a commission, but it will not charge you anything extra. Please review our affiliate link disclosure for more information.
Users prescribed Suboxone could benefit from a $500,000 FTC settlement for false advertising and antitrust violations.
Contents
- Suboxone Lawsuit Claim
- Suboxone Maker Reckitt Benckiser To Pay $1.4 Billion In Largest Opioid Settlement In Us History
- Indivior Agrees To Pay $385m Amid Monopoly Lawsuit
- Indivior Investor Class Action Lawsuit
- Suboxone Monopoly Suit Settled By Indivior
- New Ozempic Lawsuit Filed Over Stomach Paralysis Claims
- Indivior To Pay $385 Mln To End Final Suboxone Monopoly Lawsuits
- Suboxone Drugmaker Sued Over Alleged Antitrust Violations
- Suboxone & Tooth Decay Lawsuits
Suboxone Lawsuit Claim
The settlement benefits users who were prescribed oral Suboxone between March 1, 2013 and February 28, 2019.
Suboxone Maker Reckitt Benckiser To Pay $1.4 Billion In Largest Opioid Settlement In Us History
Suboxone is a drug used to treat opioid addiction, according to Drugs.com. The drug comes in the form of tablets and films.
According to the FTC, Reckitt Benckiser and Indivior colluded to maximize Suboxone profits at the expense of consumers. In an effort to convince more patients to take their brand-name drug, the company allegedly misled patients and doctors by claiming that the film version of Suboxone was safer than the tablet version.
In order to profit from this alleged false advertising, Reckitt Benckiser and Indivior suppressed generic competition by filing “baseless” petitions with the US Food and Drug Administration (FDA), the FTC asserted. The petition reportedly reiterates unsupported safety claims about the film version of Suboxone and urges the FDA to reject the application for a generic pill substitute.
The FTC says this action causes consumers to pay more for Suboxone, when, in a healthy market, they would be able to buy a cheaper generic version of the drug.
Indivior Agrees To Pay $385m Amid Monopoly Lawsuit
In July 2020, Reckitt Benckiser agreed to a $50 million settlement to resolve these claims. Shortly thereafter, Indivior agreed to pay $10 million to settle the allegations.
In May 2021, the Federal Trade Commission distributed more than $59 million to users who were prescribed Suboxone. Of this, $42 million was sent in the form of 37,212 checks, while the remaining $16 million was sent in the form of 14,663 prepaid debit cards. 51,875 paid an average of $1,139.
With the remaining $500,000 from the settlement fund, the FTC distributed payments to consumers who submitted valid claim forms.
These payments are only available to consumers who contact a claims administrator after the original 2021 claim deadline and request to be placed on a waiting list for payment. Consumers cannot file a claim if they have not added their name to the waiting list by September 2021, even if they are eligible for payment.
Indivior Investor Class Action Lawsuit
There is no deadline for exceptions or objections listed on the settlement website. The FTC’s Suboxone settlement is not subject to final court approval.
To receive payment from the FTC’s Suboxone settlement, users must submit a valid claim form by November 26, 2022. To file a claim, users must use the ID number they received via email or mail.
. You also harm other eligible class members by filing fraudulent claims. If you are not sure if you qualify, please read the Frequently Asked Questions section of the Adjuster’s website to make sure you meet all the criteria (Non-Adjuster Top Class Actions). If you are not eligible for this settlement, see our database of other open class action settlements that you may be eligible for.
Federal Trade Commission v. Indivior, Civil Action No. 20-cv-00036, in U.S. District Court. for the Western District of Pennsylvania
Suboxone Monopoly Suit Settled By Indivior
Federal Trade Commission v. Reckitt Benckiser Group PLC, Civil Action No. 1:19-CV-00028, in U.S. District Court. for the Western District of Pennsylvania
Please note: Top Class Action is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury claims and product liability claims. Top Class Action does not process claims and we cannot advise you of the status of any class action settlement claim. You should contact your adjuster or attorney for any updates on the status of your claim, claim forms or questions about when payments are expected to be sent.
We use cookies to improve functionality and performance, improve user experience and provide personalized content. Click Accept if you agree. Click “Change settings” if you want to adjust your use of cookies.
Select the cookies you want to allow. You can change these settings at any time. However, this may make some functions unavailable. For information on deleting cookies, please refer to your browser’s help function. Learn more about the cookies we use. This settlement benefits individuals and entities who purchased or indirectly paid for Suboxone and its AB-rated generic equivalent for themselves, their families, employees, plan participants, beneficiaries or insured persons between December 22, 201 and 1. And August 21, 2023 , in some US states.
New Ozempic Lawsuit Filed Over Stomach Paralysis Claims
Top Class Actions website and social media posts use affiliate links. If you make a purchase using this link, we may receive a commission, but it will not charge you anything extra. Please review our affiliate link disclosure for more information.
Indivior has agreed to settle a $30 million antitrust class action lawsuit to resolve allegations that it colluded with other companies to raise the cost of Suboxone, a treatment for opioid addiction.
This settlement benefits individuals and entities who purchased or indirectly paid for Suboxone and its class AB generic equivalent for themselves, their families, employees, plan participants, beneficiaries or insured persons between December 22, 2011 and December 1 and August 21, 2023 Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana , Nebraska, Nevada, New Hampshire , New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia , Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia.
The antitrust class action lawsuit accuses Indivior of colluding with other companies to raise the price of Suboxone and its generic alternatives. According to the plaintiffs in the case, they were forced to pay more for Suboxone as a result of the antitrust scheme.
Indivior To Pay $385 Mln To End Final Suboxone Monopoly Lawsuits
Indivior did not admit any wrongdoing but agreed to a $30 million settlement to resolve the antitrust class action claim.
Under the terms of the Suboxone Class Action Settlement, Class Members may receive a prorated portion of the Net Settlement Fund based on the amount they spend on eligible purchases. The exact payment will vary depending on the number of claims submitted and other factors.
A final approval hearing for the Suboxone antitrust class action settlement is scheduled for October 19, 2023.
To receive a settlement payment, class members must submit a valid claim form by February 17, 2024.
Suboxone Drugmaker Sued Over Alleged Antitrust Violations
Individuals and entities who purchased or indirectly paid for Suboxone and class AB generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insured persons between December 22, 2011 and August 21, 2023, in Alabama, Alaska, Arizona, Arkansas , California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New York Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin , Wyoming and the District of Columbia
Records from Class Members’ pharmacies showing that they purchased Suboxone and class AB generic equivalents at least once or a note or record from their doctor describing the amount of Suboxone and class AB generic equivalents prescribed.
Class members may have a claim even if they are unable to provide any of the above claim documents as long as they provide a certification on the claim form. However, the Settlement Administrator may request additional claim documents from those who have not submitted the above documents after the Class Member has submitted his claim form.
. You also harm other eligible class members by filing fraudulent claims. If you are not sure if you qualify, please read the Frequently Asked Questions section of the Adjuster’s website to make sure you meet all the criteria (Non-Adjuster Top Class Actions). If you are not eligible for this settlement, see our database of other open class action settlements that you may be eligible for.
Suboxone & Tooth Decay Lawsuits
Please note: Top Class Action is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury claims and product liability claims. Top Class Action does not process claims and we cannot advise you of the status of any class action settlement claim. You should contact your adjuster or attorney for any updates on the status of your claim, claim forms or questions about when payments are expected to be sent.
We use cookies to improve functionality and performance, improve user experience and provide personalized content. Click Accept if you agree. Click “Change settings” if you want to adjust your use of cookies.
Select the cookies you want to allow. You can change these settings at any time. However, this may make some functions unavailable. For information on deleting cookies, please refer to your browser’s help function. Learn more about the cookies we use. Suboxone Tooth Damage Lawsuit If you have been using Suboxone and suffered tooth decay or serious dental complications, you may be eligible.
Class action lawsuit suboxone, lawsuit against suboxone, suboxone lawsuit, small claim lawsuit, suboxone tooth decay lawsuit, suboxone teeth lawsuit, facebook lawsuit claim, claim lawsuit settlements, roundup class action lawsuit claim form, suboxone malpractice lawsuit, lawsuit claim, reckitt benckiser suboxone lawsuit